Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole): clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

3

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
Breast cancer	1
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer	1

Recruiting trials involving Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
NCT05190094 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations

Common questions

How many recruiting trials involve Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.